Cargando…
Transcriptome profiling reveals novel gene expression signatures and regulating transcription factors of TGF β‐induced epithelial‐to‐mesenchymal transition
Dysregulated epithelial to mesenchymal transition (EMT) in cancer cells endows invasive and metastatic properties upon cancer cells that favor successful colonization of distal target organs and therefore play a critical role in transforming early‐stage carcinomas into invasive malignancies. EMT has...
Autores principales: | Du, Liutao, Yamamoto, Shota, Burnette, Barry L., Huang, Danshang, Gao, Kun, Jamshidi, Neema, Kuo, Michael D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971924/ https://www.ncbi.nlm.nih.gov/pubmed/27318801 http://dx.doi.org/10.1002/cam4.719 |
Ejemplares similares
-
Epithelial–mesenchymal transition and its transcription factors
por: Debnath, Pallabi, et al.
Publicado: (2021) -
Mesenchymal stromal cells induce epithelial-to-mesenchymal transition in human colorectal cancer cells through the expression of surface-bound TGF-β
por: Mele, Valentina, et al.
Publicado: (2014) -
Distinct interactors define the p63 transcriptional signature in epithelial development or cancer
por: Pecorari, Rosalba, et al.
Publicado: (2022) -
20(S)-ginsenoside Rh2 as agent for the treatment of LMN-CRC via regulating epithelial–mesenchymal transition
por: Yuan, Yihang, et al.
Publicado: (2020) -
microRNA-217 suppressed epithelial-to-mesenchymal transition through targeting PTPN14 in gastric cancer
por: Chen, Gen, et al.
Publicado: (2020)